Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
44°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Edwards Lifesciences
(NY:
EW
)
86.96
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edwards Lifesciences
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
July 11, 2023
Via
Benzinga
Peering Into Edwards Lifesciences's Recent Short Interest
July 07, 2023
Via
Benzinga
Analyst Ratings for Edwards Lifesciences
June 27, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 10 Years
June 26, 2023
Via
Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $7,400 Today
June 08, 2023
Via
Benzinga
Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction
June 02, 2023
Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients.
Via
Benzinga
The Latest Analyst Ratings for Edwards Lifesciences
May 30, 2023
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today
May 24, 2023
Via
Benzinga
Will Investors Notice Exciting Sign On Edwards Lifesciences's Chart?
May 11, 2023
Via
Benzinga
Here's How Much $1000 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth Today
May 09, 2023
Via
Benzinga
Piper Sandler Maintains Neutral Rating for Edwards Lifesciences: Here's What You Need To Know
April 27, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 12, 2023
Via
Benzinga
3 Medical Device Stocks Outpacing the Healthcare Industry This Year
May 01, 2023
All three of these companies have seen double-digit increases in their share prices this year.
Via
The Motley Fool
Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review
April 28, 2023
Microsoft, Meta, Cloudflare and Crocs were among the many big movers.
Via
Investor's Business Daily
This Is What Whales Are Betting On Edwards Lifesciences
April 26, 2023
Via
Benzinga
The Latest Analyst Ratings for Edwards Lifesciences
April 24, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 5 Years
April 24, 2023
Via
Benzinga
The Latest Analyst Ratings for Edwards Lifesciences
March 29, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 27, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 26, 2023
Via
Benzinga
eBay To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday
April 25, 2023
B of A Securities cut the price target for Catalent, Inc. (NYSE: CTLT) from $78 to $49. B of A Securities analyst Derik De Bruin maintained a Neutral rating. Catalent shares fell 0.2% to $44.83 in...
Via
Benzinga
3 No-Brainer Medical Device Stocks to Buy Right Now
April 06, 2023
These companies have consistently delivered revenue and EPS gains.
Via
The Motley Fool
Looking Into Edwards Lifesciences's Recent Short Interest
March 15, 2023
Via
Benzinga
Expert Ratings for Edwards Lifesciences
March 08, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
March 29, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023
March 08, 2023
Via
Benzinga
Interview With David Rolfe of Wedgewood Partners
February 17, 2023
Motley Fool analyst John Rotonti recently seized the opportunity to interview David Rolfe.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
February 06, 2023
Via
Benzinga
Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 4
February 04, 2023
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street’s best analysts during the week of Jan. 30 through Feb. 3.
Via
Talk Markets
Edwards Lifesciences Q4 Earnings Beats Street Estimates, Expects Easing Of Macro Headwinds Later In 2023
February 01, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.